Home
Scholarly Works
A phase I study of R04929097, an oral gamma...
Conference

A phase I study of R04929097, an oral gamma secretase inhibitor, in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

Authors

Richter S; McWhirter E; Chen EX; Ben T; Hotte SJ; Stathis A; Hirte HW; Razak ARA; Laughlin A; Wang L

Volume

30

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2012

Name of conference

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

Chicago, IL

Conference start date

June 1, 2012

Conference end date

June 6, 2012

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team